Advanced Therapy Medicinal Products (ATMPs) – Page 3

Cryopreservation failure during ATMP manufacturing: patient safety impact and disposition

Identifying the symptoms or signals of a cryopreservation failure is the first step in investigation. Common indicators include:Click to read the full article.

Vector potency drift during stability testing: inspection-ready investigation package

Identifying symptoms or signals of vector potency drift early is crucial for timely intervention. Symptoms may include:Click to read the full article.

Chain of identity breach during stability testing: patient safety impact and disposition

Identifying symptoms that indicate a potential chain of identity breach during stability testing is vital. Some key signals include:Click to read the full article.

Vector potency drift during stability testing: regulatory risk assessment and CAPA

Identifying early signals of vector potency drift is crucial for timely intervention and effective investigations. Common symptoms may include:Click to read the full article.

Cryopreservation failure during tech transfer: regulatory risk assessment and CAPA

Identifying the symptoms and signals of a cryopreservation failure is crucial for immediate containment and subsequent investigation. These symptoms can vary but generally manifest in the following ways:Click to read…

Aseptic manipulation deviation during ATMP manufacturing: regulatory risk assessment and CAPA

Recognizing the initial signals of a deviation is crucial. Symptoms may manifest in various ways, including:Click to read the full article.

Aseptic manipulation deviation during tech transfer: regulatory risk assessment and CAPA

Recognizing symptoms of aseptic manipulation deviations is essential for timely intervention. Common indicators include:Click to read the full article.

Chain of identity breach during scale-up: inspection-ready investigation package

Identifying symptoms of a chain of identity breach is crucial for early intervention. Common signals include:Click to read the full article.

Aseptic manipulation deviation during ATMP manufacturing: patient safety impact and disposition

Recognizing the initial signs of a potential aseptic manipulation deviation is crucial for timely intervention and investigation. Symptoms may manifest in multiple forms and can include:Click to read the full…

Cryopreservation failure during FDA inspection readiness: patient safety impact and disposition

The first step in addressing a cryopreservation failure is recognizing the symptoms or signals that indicate an issue may have occurred. Symptoms can manifest in various ways, such as:Click to…

Cryopreservation failure during stability testing: patient safety impact and disposition

Detecting cryopreservation failures early is critical. Notably, symptoms may manifest as:Click to read the full article.

Vector potency drift during stability testing: patient safety impact and disposition

Identifying the symptoms of vector potency drift is the first critical step in addressing the issue. Terms such as Out of Specification (OOS) results during stability testing typically raise alarm…